Regulus Therapeutics Inc. Quarterly Return On Assets in % from Q2 2013 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Regulus Therapeutics Inc. quarterly/annual Return On Assets history and growth rate from Q2 2013 to Q3 2024.
  • Regulus Therapeutics Inc. Return On Assets for the quarter ending September 30, 2024 was -48.6 %, a 30.3% increase year-over-year.
  • Regulus Therapeutics Inc. annual Return On Assets for 2023 was -80.6 %, a 52.2% decline from 2022.
  • Regulus Therapeutics Inc. annual Return On Assets for 2022 was -52.9 %, a 4.46% increase from 2021.
  • Regulus Therapeutics Inc. annual Return On Assets for 2021 was -55.4 %, a 14.2% decline from 2020.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -48.6 +21.1 +30.3% Jul 1, 2024 Sep 30, 2024
Q2 2024 -49.4 +14.1 +22.3% Apr 1, 2024 Jun 30, 2024
Q1 2024 -55.5 +5.01 +8.29% Jan 1, 2024 Mar 31, 2024
Q4 2023 -80.6 -27.6 -52.2% Oct 1, 2023 Dec 31, 2023
Q3 2023 -69.7 -21.1 -43.4% Jul 1, 2023 Sep 30, 2023
Q2 2023 -63.5 -11.1 -21.1% Apr 1, 2023 Jun 30, 2023
Q1 2023 -60.5 -9.08 -17.7% Jan 1, 2023 Mar 31, 2023
Q4 2022 -52.9 +2.47 +4.46% Oct 1, 2022 Dec 31, 2022
Q3 2022 -48.6 +3.15 +6.09% Jul 1, 2022 Sep 30, 2022
Q2 2022 -52.5 -13.9 -35.9% Apr 1, 2022 Jun 30, 2022
Q1 2022 -51.4 -4.4 -9.37% Jan 1, 2022 Mar 31, 2022
Q4 2021 -55.4 -6.88 -14.2% Oct 1, 2021 Dec 31, 2021
Q3 2021 -51.8 +5.77 +10% Jul 1, 2021 Sep 30, 2021
Q2 2021 -38.6 +33.7 +46.6% Apr 1, 2021 Jun 30, 2021
Q1 2021 -47 +21.5 +31.4% Jan 1, 2021 Mar 31, 2021
Q4 2020 -48.5 +19.7 +28.9% Oct 1, 2020 Dec 31, 2020
Q3 2020 -57.5 +36.3 +38.7% Jul 1, 2020 Sep 30, 2020
Q2 2020 -72.3 +27.8 +27.8% Apr 1, 2020 Jun 30, 2020
Q1 2020 -68.5 +40.6 +37.2% Jan 1, 2020 Mar 31, 2020
Q4 2019 -68.2 +43.8 +39.1% Oct 1, 2019 Dec 31, 2019
Q3 2019 -93.8 +3.73 +3.82% Jul 1, 2019 Sep 30, 2019
Q2 2019 -100 -14.2 -16.5% Apr 1, 2019 Jun 30, 2019
Q1 2019 -109 -16.3 -17.5% Jan 1, 2019 Mar 31, 2019
Q4 2018 -112 -19.4 -21% Oct 1, 2018 Dec 31, 2018
Q3 2018 -97.6 -4.65 -5.01% Jul 1, 2018 Sep 30, 2018
Q2 2018 -86 +4.49 +4.96% Apr 1, 2018 Jun 30, 2018
Q1 2018 -92.8 -17.3 -22.9% Jan 1, 2018 Mar 31, 2018
Q4 2017 -92.6 -23.7 -34.3% Oct 1, 2017 Dec 31, 2017
Q3 2017 -92.9 -39.3 -73.4% Jul 1, 2017 Sep 30, 2017
Q2 2017 -90.5 -44.4 -96.2% Apr 1, 2017 Jun 30, 2017
Q1 2017 -75.6 -31.2 -70.2% Jan 1, 2017 Mar 31, 2017
Q4 2016 -68.9 -31.7 -85.3% Oct 1, 2016 Dec 31, 2016
Q3 2016 -53.6 -8.7 -19.4% Jul 1, 2016 Sep 30, 2016
Q2 2016 -46.1 -0.38 -0.83% Apr 1, 2016 Jun 30, 2016
Q1 2016 -44.4 -2.22 -5.27% Jan 1, 2016 Mar 31, 2016
Q4 2015 -37.2 +6.96 +15.8% Oct 1, 2015 Dec 31, 2015
Q3 2015 -44.9 -13.5 -43.2% Jul 1, 2015 Sep 30, 2015
Q2 2015 -45.7 -22.3 -95% Apr 1, 2015 Jun 30, 2015
Q1 2015 -42.2 -21.6 -105% Jan 1, 2015 Mar 31, 2015
Q4 2014 -44.2 -27.3 -162% Oct 1, 2014 Dec 31, 2014
Q3 2014 -31.3 -9.04 -40.5% Jul 1, 2014 Sep 30, 2014
Q2 2014 -23.4 +9.09 +28% Apr 1, 2014 Jun 30, 2014
Q1 2014 -20.6 Jan 1, 2014 Mar 31, 2014
Q4 2013 -16.9 Oct 1, 2013 Dec 31, 2013
Q3 2013 -22.3 Jul 1, 2013 Sep 30, 2013
Q2 2013 -32.5 Apr 1, 2013 Jun 30, 2013
* An asterisk sign (*) next to the value indicates that the value is likely invalid.